Advertisements
Feeds:
Posts
Comments

Search Results for 'Acute Lymphoblastic Leukemia (ALL) '


Author: Tilda Barliya PhD Acute lymphoblastic leukemia (ALL), a malignant disorder of lymphoid progenitor cells, affects both children and adults, with peak prevalence between the ages of 2 and 5 years (2). Acute lymphocytic leukemia (ALL) is a heterogeneous disease, both in terms of its pathology and the populations that it affects. Disease pathogenesis involves a […]

Read Full Post »


Curator: Aviva Lev-Ari, PhD, RN Sunitinib brings Adult acute lymphoblastic leukemia (ALL) to Remission – RNA Sequencing – FLT3 Receptor Blockade https://pharmaceuticalintelligence.com/2012/07/09/sunitinib-brings-adult-all-to-remission-rna-sequencing/  

Read Full Post »


Sunitinib brings Adult Acute Lymphoblastic Leukemia (ALL) to Remission – RNA Sequencing – FLT3 Receptor Blockade Curator: Aviva Lev-Ari, PhD, RN Updated 11/13/2013 Pazopanib versus Sunitinib in Renal Cancer N Engl J Med 2013; 369:1968-1970November 14, 2013DOI: 10.1056/NEJMc1311795 Article To the Editor: Cancer treatments are expensive. The estimation of the total cost can be challenging […]

Read Full Post »


Inotuzumab Ozogamicin: Success in relapsed/refractory Acute Lymphoblastic Leukemia (ALL) Reporter: Aviva Lev-Ari, PhD, RN   About Inotuzumab Ozogamicin Inotuzumab ozogamicin is an investigational antibody-drug conjugate (ADC) comprised of a monoclonal antibody (mAb) targeting CD22,9 a cell surface antigen expressed on approximately 90 percent of B-cell malignancies,10 linked to a cytotoxic agent. When inotuzumab ozogamicin binds to the […]

Read Full Post »


Reporter: Aviva Lev-Ari, PhD, RN GWAS Explores Role of Inherited Variants in Childhood ALL March 20, 2013 By a GenomeWeb staff reporter NEW YORK (GenomeWeb News) – Inherited genetic variants — including some found at variable frequencies in different human populations — can significantly bump up an individual’s risk of developing acute lymphoblastic leukemia, according to […]

Read Full Post »


Curator: Aviva Lev-Ari, PhD, RN Sunitinib brings Adult acute lymphoblastic leukemia (ALL) to Remission – RNA Sequencing – FLT3 Receptor Blockade https://pharmaceuticalintelligence.com/2012/07/09/sunitinib-brings-adult-all-to-remission-rna-sequencing/  

Read Full Post »


Curator: Aviva Lev-Ari, PhD, RN Sunitinib brings Adult acute lymphoblastic leukemia (ALL) to Remission – RNA Sequencing – FLT3 Receptor Blockade https://pharmaceuticalintelligence.com/2012/07/09/sunitinib-brings-adult-all-to-remission-rna-sequencing/  

Read Full Post »


CAR-T Therapy in Leukemia Curator: Larry H. Bernstein, MD, FCAP   UCART19: First in Man Proof of Concept to be Presented at 2015 ASH Annual Meeting November 05, 2015 DOWNLOAD New York, November 5, 2015 – Cellectis (Alternext: ALCLS – Nasdaq: CLLS) today announced that Great Ormond Street Hospital (GOSH) and University College London (UCL) […]

Read Full Post »


Treatment of Acute Leukemias Author and Curator: Larry H. Bernstein, MD, FCAP 2.4.4 Treatment of Acute Leukemias Treatment of Acute Lymphoblastic Leukemia Ching-Hon Pu, and William E. Evans N Engl J Med Jan 12, 2006; 354:166-178 http://dx.doi.org:/10.1056/NEJMra052603 Although the overall cure rate of acute lymphoblastic leukemia (ALL) in children is about 80 percent, affected adults […]

Read Full Post »


Treatment for Chronic Leukemias [2.4.4B] Larry H. Bernstein, MD, FCAP, Author, Curator, Editor https://pharmaceuticalintelligence.com/2015/8/11/larryhbern/Treatment-for-Chronic-Leukemias-%5B2.4.4B%5D 2.4.4B1 Treatment for CML Chronic Myelogenous Leukemia Treatment (PDQ®) http://www.cancer.gov/cancertopics/pdq/treatment/CML/Patient/page4 Treatment Option Overview Key Points for This Section There are different types of treatment for patients with chronic myelogenous leukemia. Six types of standard treatment are used: Targeted therapy Chemotherapy Biologic therapy […]

Read Full Post »

Next »